Hamza A A Elati

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Trypanosoma Cruzi

Radiation Therapy

Top Venues

Journal of medicinal chemistry

International journal of molecular sciences

ACS medicinal chemistry letters

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

J Jonathan Nué-Martinez, David Cisneros, María Del Valle Moreno-Blázquez, Cristina Fonseca-Berzal, José Ignacio Manzano, Damien Kraeutler, Marzuq A Ungogo, Maha A Aloraini, Hamza A A Elati, Alexandra Ibáñez-Escribano, Laura Lagartera, Tomás Herraiz, Francisco Gamarro, Harry P de Koning, Alicia Gómez-Barrio, Christophe Dardonville
Synthesis and Biophysical and Biological Studies of N -Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites. Journal of medicinal chemistry (2023)
Mustafa M Aldfer, Ibrahim A Alfayez, Hamza A A Elati, Nilanjana Gayen, Ehab Kotb Elmahallawy, Ana Milena Murillo, Sabrina Marsiccobetre, Serge Van Calenbergh, Ariel M Silber, Harry P de Koning
The Trypanosoma cruzi TcrNT2 Nucleoside Transporter Is a Conduit for the Uptake of 5-F-2'-Deoxyuridine and Tubercidin Analogues. Molecules (Basel, Switzerland) 27 (22) (2022)
Mustafa M Aldfer, Tahani A AlSiari, Hamza A A Elati, Manal J Natto, Ibrahim A Alfayez, Gustavo Daniel Campagnaro, Bashiru Sani, Richard J S Burchmore, George Diallinas, Harry P de Koning
Nucleoside Transport and Nucleobase Uptake Null Mutants in Leishmania mexicana for the Routine Expression and Characterization of Purine and Pyrimidine Transporters. International journal of molecular sciences 23 (15) (2022)
David Cisneros, Eduardo J Cueto-Díaz, Tania Medina-Gil, Rebecca Chevillard, Teresa Bernal-Fraile, Ramón López-Sastre, Mustafa M Aldfer, Marzuq A Ungogo, Hamza A A Elati, Natsumi Arai, Momoka Otani, Shun Matsushiro, Chiaki Kojima, Godwin U Ebiloma, Tomoo Shiba, Harry P de Koning, Christophe Dardonville
Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies. ACS medicinal chemistry letters 13 (2) (2022)